HIGHLIGHTS
- who: Xiao Ma from the of Nebraska Medical Center, United States have published the research work: Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes, in the Journal: (JOURNAL)
- what: This study was aimed to explore the preliminary outcomes of neoadjuvant ICI plus chemotherapy followed by surgery for patients with treatment-nau00efve, locally advanced ESCC. Frontiers in Oncology | www.frontiersin.org the study shows that two cycles of preoperative ICI plus chemotherapy were well tolerated in locally-advanced ESCC patients, without therapy-related surgical delays. Several clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.